131583-69-2

Upstream product

• 2345-34-8 4-acetyloxy-benzoic acid 
• 141134-83-0 3,4-dihydro-1-(4-piperidyl)-2(1H)-quinoline hydrochloride 
• 131631-03-3 1-[1-(4-Acetoxybenzoyl)-4-piperidinyl]-3,4-dihydrocarbostyril 
• 131583-56-7 1-[1-(4-Hydroxy-benzoyl)-piperidin-4-yl]-3,4-dihydro-1H-quinolin-2-one 
• 131587-34-3 3-[2-(1-Benzyl-piperidin-4-ylamino)-phenyl]-propionamide 
• 1664-61-5 dihydrocinnamamide 
• 27914-73-4 4-acetoxybenzoyl chloride 
• 131632-66-1 3,4-dihydro-1-<1-<4-(3-phthalimidopropoxy)benzoyl>-4-piperidyl>-2(1H)-quinolinone 

Downstream Products

• 131631-89-5 OPC-21268 

Relevant academic research and scientific papers

Orally active, nonpeptide vasopressin V1 antagonists. A novel series of 1-(1-substituted 4-piperidyl)-3,4-dihydro-2(1H)-quinolinone

A series of compounds has been synthesized and demonstrated to be antagonists of V1 receptors both in vitro and in vivo. These compounds are structurally related to the 1-(4-piperidyl)-2(1H)-quinolinones, including OPC-21268, an orally bioavail